PERTH, Australia – Melbourne-based Starpharma Holdings Ltd. has entered a sales and marketing deal with Mundipharma International Ltd., which gives Mundipharma sales and marketing rights to Vivagel BV for bacterial vaginosis (BV) in Asia, the Middle East, Africa and the majority of Latin America. Read More
NEW DELHI, India – The World Bank and India have signed a $125 million loan agreement in April, under which the former pledged to support India's national initiative toward innovative biopharmaceuticals and medical devices. Read More
HONG KONG – While the South Korean government's pricing regime is helping to make drugs more affordable in the country, it is also slowing the value growth of the pharmaceutical market and pressuring the sales of innovative drugs. Read More
When the 21st century dawned, the global marketing map for U.S. drug and device companies looking to expand came with one simple direction: Follow the BRIC road. Read More
Lipimetix Development Inc., of Natick, Mass., said Anji Pharmaceuticals Inc., of China, entered a licensing deal for the Lipimetix platform of peptides (AEM-28 and analogues) for development in mainland China, Taiwan and Hong Kong. Terms include an up-front payment of $2 million, multiple additional cash payments upon achievement of clinical/regulatory milestones and a royalty on Anji Pharma's future pharmaceutical revenues derived from the program. Read More
Beigene Ltd., of Beijing, appointed Xiaobin Wu general manager of China and president. Wu has more than 25 years of experience in the pharmaceutical industry, including 17 years leading China operations of multinational companies, with expertise in integrated research and development, strategy, commercialization and general management. Read More
